Zoetis Inc. Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory
Zoetis Inc. (ZTS) reported Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory of $18.00 million for the 5-month period ending 2018-12-31, per its 10-K filed 2019-02-14.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory · last filed 2019-02-14
- Zoetis Inc. business combination, provisional information, initial accounting incomplete, adjustment, inventory for the quarter ending 2018-09-30 was $7.00M, a 36.36% decline year-over-year.
- Zoetis Inc. business combination, provisional information, initial accounting incomplete, adjustment, inventory for the quarter ending 2017-10-01 was $11.00M.
| Period end | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory 3 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory 5 month | Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Inventory 9 month |
|---|---|---|---|
| 2018-12-31 | $18.00M 10-K · filed 2019-02-14 | ||
| 2018-09-30 | $7.00M 10-Q · filed 2018-11-01 | ||
| 2017-10-01 | $11.00M 10-Q · filed 2018-11-01 | $33.00M 10-Q · filed 2018-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |